Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cellsDaniel Veigel(Comprehensive Cancer Center Vienna), Thomas W. Grunt(Comprehensive Cancer Center Vienna)International Journal of CancerOctober 10, 201410.1002/ijc.29261Cited by 62SaveCiteExport RISWatch citationsRelated PapersMulti-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells|Oncotarget|2017|57Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells|Oncotarget|2018|28Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer|Cancers|2022|10